220 related articles for article (PubMed ID: 23190403)
1. Exacerbation of lymphomatoid papulosis during rituximab therapy.
McCurdy O; McCormack C; Ritchie D; Prince HM
Australas J Dermatol; 2014 Feb; 55(1):e1-3. PubMed ID: 23190403
[TBL] [Abstract][Full Text] [Related]
2. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
Robak T; Lech-Maranda E; Robak P
Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
[TBL] [Abstract][Full Text] [Related]
3. [Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab].
Tsukasaki K
Nihon Rinsho; 2015 Feb; 73 Suppl 2():632-5. PubMed ID: 25831837
[No Abstract] [Full Text] [Related]
4. Lymphomatoid papulosis from childhood with anaplastic large-cell lymphoma of the small bowel.
Perna AG; Jones DM; Duvic M
Clin Lymphoma; 2004 Dec; 5(3):190-3. PubMed ID: 15636695
[TBL] [Abstract][Full Text] [Related]
5. [Chronic lymphocytic leukemia].
Aoki S
Rinsho Ketsueki; 2014 Feb; 55(2):213-22. PubMed ID: 24598189
[No Abstract] [Full Text] [Related]
6. Chronic Pneumocystis jiroveci presenting as asymptomatic granulomatous pulmonary nodules in lymphoma.
Kumar N; Bazari F; Rhodes A; Chua F; Tinwell B
J Infect; 2011 Jun; 62(6):484-6. PubMed ID: 21592582
[TBL] [Abstract][Full Text] [Related]
7. Early initial therapy of advanced follicular lymphoma: the need for vigilance.
Sweetenham JW; Freedman AS
Leuk Lymphoma; 2011 Mar; 52(3):355-7. PubMed ID: 21323517
[No Abstract] [Full Text] [Related]
8. Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy.
Pei SN; Ma MC; Wang MC; Kuo CY; Rau KM; Su CY; Chen CH
Ann Hematol; 2012 Jul; 91(7):1007-12. PubMed ID: 22273839
[TBL] [Abstract][Full Text] [Related]
9. Richter syndrome in chronic lymphocytic leukaemia manifesting only as tumorous hepatomegaly.
Tadmor T; Bejar J; Attias D; Polliack A
Br J Haematol; 2011 Oct; 155(2):135. PubMed ID: 21973072
[No Abstract] [Full Text] [Related]
10. Progressive multifocal leukoencephalopathy after treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia.
Herold T; Seiler T; Egensperger R; Trumm C; Bergmann M; Franke D; Mumm FF; Schinwald N; Buske C; Dreyling M
Leuk Lymphoma; 2012 Jan; 53(1):169-72. PubMed ID: 21812535
[No Abstract] [Full Text] [Related]
11. Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-Hodgkin lymphoma.
Tam CS; Wolf M; Prince HM; Januszewicz EH; Westerman D; Lin KI; Carney D; Seymour JF
Cancer; 2006 Jun; 106(11):2412-20. PubMed ID: 16649223
[TBL] [Abstract][Full Text] [Related]
12. Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies.
Cummins DL; Mimouni D; Tzu J; Owens N; Anhalt GJ; Meyerle JH
J Am Acad Dermatol; 2007 Jan; 56(1):153-9. PubMed ID: 17097371
[TBL] [Abstract][Full Text] [Related]
13. Severe infusion-related reactions are uncommon in rituximab-treated CLL patients in clinical practice: results from a Swedish national observational study.
Norin S; Björkstrand B; Rommel F; Timberg L; Andersson PO; Häggström J; Aldrin A; Hansson L
Leuk Res; 2015 Jan; 39(1):33-7. PubMed ID: 25499233
[TBL] [Abstract][Full Text] [Related]
14. [Subcutaneous panniculitis-like T-cell lymphoma following treatment with rituximab and cyclophosphamide].
Schmutz JL; Trechot P
Ann Dermatol Venereol; 2013 Mar; 140(3):246-7. PubMed ID: 23466166
[No Abstract] [Full Text] [Related]
15. Early cryptococcal meningitis following treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia.
Marchand T; Revest M; Tattevin P; Chevrier S; Poullot E; Lamy T; Houot R
Leuk Lymphoma; 2013 Mar; 54(3):643-5. PubMed ID: 22924391
[No Abstract] [Full Text] [Related]
16. Co-existent primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis.
Dawn G; Morrison A; Morton R; Bilsland D; Jackson R
Clin Exp Dermatol; 2003 Nov; 28(6):620-4. PubMed ID: 14616830
[TBL] [Abstract][Full Text] [Related]
17. [Occipital neuralgia (Arnold) as the presenting symptom of diffuse large B-cell non-Hodgkin lymphoma].
Bruneau O; Le Moigne F; Guyotat J; Nicolas-Virelizier E; Guilloton L; Drouet A
Rev Neurol (Paris); 2013 Feb; 169(2):175-8. PubMed ID: 23079854
[No Abstract] [Full Text] [Related]
18. Bendamustine and rituximab for indolent B-cell non-hodgkin lymphoma in patients with compensated hepatitis C cirrhosis: a case series.
Parker SM; Hyder MA; Fesler MJ
Clin Lymphoma Myeloma Leuk; 2013 Dec; 13(6):e15-7. PubMed ID: 24060287
[No Abstract] [Full Text] [Related]
19. Lymphomatoid papulosis and Ki-1+ anaplastic large cell lymphoma occurring concurrently in a pediatric patient.
Rifkin S; Valderrama E; Lipton JM; Karayalcin G
J Pediatr Hematol Oncol; 2001; 23(5):321-3. PubMed ID: 11464993
[TBL] [Abstract][Full Text] [Related]
20. [Modern times: back to past, back to future].
Feliu J; Zabalza A; García-Muñoz R; Olavarría E
Med Clin (Barc); 2012 Jul; 139(4):180-1. PubMed ID: 22281094
[No Abstract] [Full Text] [Related]
[Next] [New Search]